logo

Lyka Labs Ltd. Financials

11:29 Jun 19

Lyka Labs Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
112.38
-1.79 (-1.57%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Lyka Labs Ltd. Financials

Lyka Labs Ltd.
Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
112.38
-1.79 (-1.57%)
11:29 Jun 19
Quality
image/svg+xml

71/100
High Financial Strength

Valuation
image/svg+xml

42/100
Mid Valuation

Technical

39/100
Technically Neutral

Strength

9

Weakness

3

Opportunity

1

Threats

0

7.73 %

ROE %

4.54 %

ROA %

2.25

EPS

29.01

BVPS

5.78 %

Net Profit Margin

Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Net Sales
86.25 194.08 93.07 111.19 138.5
Operating Expenses +
66.57 92.93 76.23 95.48 120.56
Raw Material
34.91 53.39 38.77 45.63 56.95
Increase Decrease in Cost
3.06 -0.41 -1.21 -0.78 -1.36
Other Manufacturing Expense
0 0 0 0 0
Employee Cost
14.57 18.06 18.61 26.77 34.63
Miscellaneous Expenses
59.23 74.79 51.44 50.84 70.1
Operating Profit
19.68 101.15 16.84 15.71 17.94
Other Income
1.56 2.09 3.4 1.45 2.23
Depreciation
8.32 17.35 14.15 12.8 6.77
Interest
25.94 20.13 11.87 4.89 2.27
Profit before tax and exceptio..
-13.02 65.77 -5.78 -0.52 11.12
Exceptional Items
-1.13 -6.52 -7.39 -0.41 0
PBT
-14.14 59.25 -13.17 -0.93 11.12
Provision for Taxation
-4.05 20.8 -0.02 1.69 3.19
Net Profit
-10.09 38.44 -13.15 -2.62 7.93
NET Profit after MI
-11.55 39 -13.21 -2.49 8.01
EPS
-4.07 13.57 -4.63 -0.79 2.22
Operating Profit Margin (%)
22.82 52.12 18.09 14.13 12.95
Net Profit Margin (%)
-13.39 20.09 -14.19 -2.24 5.78

Lyka Labs Ltd. Shareholding

Promoter

FII

Public

Mutual Funds

Other Institutions

All Data in Percentage (%)

Mar 25 Dec 24 Sep 24 Jun 24 Mar 24
Promoter 58.20 58.10 58.10 58.10 54.80
FII 0.20 0.20 0.20 0.20 0.20
MF 0.00 0.00 0.00 0.00 0.00
Others 0.70 0.60 0.60 0.70 0.90
Shareholder Shares Holding %
Research 360 logo
Download Our App On: